PHARMA & DISTRIBUTION

Pharma Distribution Manager HCP Advisory & Medical Sample Push Behaviour Survey

Pharma distribution managers evaluate, compare, and navigate HCP advisory frequency, sample allocation priorities, and product push decisions, so you can sharpen field force positioning, fix sample conversion gaps, and benchmark channel segmentation.

Pan-India sample
Distribution Managers (HCP-facing, sample-authorised)
15-20 min
Talk to a Survey Consultant
Advisory friction & push gapsIdentify where distribution managers stall on HCP advisory or sample push decisions.
Sample allocation & conversion signalsMap sample deployment patterns against HCP tier, product category, and conversion stage.
TRUSTED BY LEADING BRANDS
Brand 0Brand 1Brand 2Brand 3Brand 4Brand 5Brand 6Brand 7Brand 8Brand 9Brand 10Brand 11Brand 12Brand 13Brand 14Brand 15Brand 16Brand 17Brand 18Brand 19Brand 20Brand 21Brand 22Brand 23Brand 24Brand 25Brand 26Brand 27Brand 28Brand 29Brand 30Brand 31

CONTEXT & RELEVANCE

Why run this survey now

Most pharma distribution managers don't lose HCP mindshare purely on sample volume. They lose it due to misaligned detailing cadence, weak advisory credibility, poor sample-to-prescription conversion, distributor-level message drift, and inconsistent last-mile follow-through, none of which fully show up in secondary sales data or CRM call logs.

If you are...

  • Pharma regional distribution manager
  • Medical representative territory lead
  • Brand or product planning manager
  • Trade channel and stockist head
  • Commercial or sales strategy lead

You're likely facing...

  • Sample push vs. prescription pull gap
  • HCP advisory trust: rep vs. KOL
  • Detailing frequency vs. recall mismatch
  • Stockist-level sample leakage patterns
  • Conversion drop: sample receipt to Rx

This will help answer...

  • HCP advisory influence on Rx decision
  • Sample-to-prescription conversion drivers
  • Segment preference by specialty or tier
  • Optimal detailing cadence and format
  • Rep credibility vs. switching triggers

RESEARCH THEMES

What This Survey Investigates

Eight interconnected research themes that map the complete distribution manager journey from HCP engagement initiation to sample conversion.

TENETS 01

HCP Engagement Patterns

  • Call frequency by specialty segment
  • Detailing session depth, format
TENETS 02

Sample Push Triggers

  • Conditions driving sample disbursement decisions
  • New launch vs. lifecycle stage priority
TENETS 03

Advisory Influence Mapping

  • KOL vs. field rep advisory weight
  • CME, webinar, peer referral impact
TENETS 04

Distribution Channel Gaps

  • Stockist-to-clinic last-mile friction
  • Sample cold chain, expiry loss rate
TENETS 05

Prescription Conversion Rate

  • Sample-to-script conversion benchmarks
  • Repeat prescription pull-through lag
TENETS 06

Compliance & Reporting

  • Sample accountability, MCI guideline adherence
  • Digital vs. manual reporting coverage
TENETS 07

Rep Capability & Incentives

  • Medical rep product knowledge depth
  • Incentive structure, target alignment
TENETS 08

Competitive Sample Dynamics

  • Rival brand sample frequency, SKU depth
  • HCP switching signals, share-of-voice gaps

SAMPLING STRATEGY

Tell us about your ideal sample

Help us understand your target respondent profile. Select what applies, we'll design the optimal sample plan based on your inputs.

Sample size
How many respondents do you need?
Not Selected
Target audience
Who should we survey?
Not Selected
Region
Which regions should we cover?
Not Selected
Segments
How should we slice the data?
Not Selected
Discuss sample plan

METHODOLOGY

Survey approach

For the Pharma Distribution Manager HCP Advisory and Medical Sample Push Behaviour Survey, we recommend a quant-first design with flexible data-collection modes to balance reach, depth, and verification.

PRIMARY
Online web surveySelf-administered survey shared via email / panels to capture structured responses at scale.
Best for
1
Ranking HCP advisory frequency by therapy area
2
Quantifying sample push triggers and refusal rates
3
Comparing behaviour across distributor tiers and regions
Deliverables
Advisory frequency index
Sample push scorecard
Tier-wise behaviour matrix
OPTIONAL
CATI (phone survey)Interviewer-led telephone interviews to reach owners who are harder to get online.
Best for
1
Field-based distributors with low digital access
2
Rapid coverage across Tier 2 and Tier 3 markets
Deliverables
Field rep coverage
Call-log diagnostics
SELECTIVE
Face-to-faceOn-ground surveys or interviews in key industrial clusters or high-value cohorts.
Best for
1
Senior distribution managers handling high-value specialty portfolios
2
Clusters with complex multi-brand sample allocation dynamics
Deliverables
Cluster behaviour maps
HCP advisory profiles
OPTIONAL
FGDs
Deliverables
Verbatim themes
Script refinement notes
OPTIONAL
Mixed surveysAny 4-mode combo Online + CATI + F2F + FGDs to maximise reach and representation. Mode-specific quotas and weighting for clean comparisons.
Deliverables
Unified dataset
Mode-adjusted analytics
Our Recommendation
Start with: Online web survey as the core quant layer, supported by CATI to capture field-based distribution managers in Tier 2 and Tier 3 markets with limited digital access.
Consider adding: Face-to-face interviews for senior managers handling specialty or high-value portfolios, plus a focused FGD layer to pressure-test sample push rationale and HCP advisory scripts.

EXECUTION PROCESS

How we execute

A proven 9-step process from scoping to delivery, designed to ensure quality, speed, and actionable insights.

Define the decision frame

Confirm objectives, target cohorts, geographies, and reporting cuts

Step 01

Define the decision frame

Design the instrument

Build workstream modules mapped to outputs (drivers, friction, pricing, retention, trust)

Step 02

Design the instrument

Lock the questionnaire

Review wording, sequencing, LOI, and competitive context; approve final version

Step 03

Lock the questionnaire

Pilot and calibrate

Test comprehension and ease quality; refine quotas and remove friction where needed

Step 04

Pilot and calibrate

Run fieldwork

Execute collection with active quota management and feasibility controls

Step 05

Run fieldwork

Assure quality

Dedupe, attention checks, speed/consistency rules, removals with audit trail

Step 06

Assure quality

Prepare the dataset

Clean data and deliver codebook/variable definitions

Step 07

Prepare the dataset

Analyse and synthesise

Driver ranking, leakage diagnostics, pricing bands, segment insights

Step 08

Analyse and synthesise

Deliver and align

Executive deck (optional dashboard) and leadership readout with recommendations

Step 09

Deliver and align

COMMERCIAL TERMS

Request a Commercial Proposal

Pricing depends on cohort, geography, sample size, approach, LOI, and deliverables. Configure below for an indicative estimate.

Select Sample Size

100

Geography

  • India
  • APAC (Singapore, Vietnam, Philippines, Indonesia, Australia, NZ, Japan, Thailand)
  • Middle East (UAE, KSA, Qatar, Bahrain, Oman, Kuwait)
  • North America (US, Canada)
  • Europe
  • Africa (South Africa, Kenya, Nigeria, Egypt, Algeria)
  • LATAM (Brazil, Mexico)

Select Mode of Survey

  • Online
  • CATI
  • Online FGD (5 people per FGD)
  • F2F

Length of the Interview

  • Select
  • 0-15
  • 16-20
  • 21-30
  • 31-45
  • 46-60
  • Custom
Indicative Estimate
  • Indian Rupee (INR)
  • United Arab Emirates Dirham (AED)
  • Afghan Afghani (AFN)
  • Albanian Lek (ALL)
  • Armenian Dram (AMD)
  • Netherlands Antillean Guilder (ANG)
  • Angolan Kwanza (AOA)
  • Argentine Peso (ARS)
  • Australian Dollar (AUD)
  • Aruban Florin (AWG)
  • Azerbaijani Manat (AZN)
  • Bosnia-Herzegovina Convertible Mark (BAM)
  • Barbadian Dollar (BBD)
  • Bangladeshi Taka (BDT)
  • Bulgarian Lev (BGN)
  • Bahraini Dinar (BHD)
  • Burundian Franc (BIF)
  • Bermudian Dollar (BMD)
  • Brunei Dollar (BND)
  • Bolivian Boliviano (BOB)
  • Brazilian Real (BRL)
  • Bahamian Dollar (BSD)
  • Bhutanese Ngultrum (BTN)
  • Botswana Pula (BWP)
  • Belarusian Ruble (BYN)
  • Belize Dollar (BZD)
  • Canadian Dollar (CAD)
  • Congolese Franc (CDF)
  • Swiss Franc (CHF)
  • Chilean Peso (CLP)
  • Chinese Yuan (CNY)
  • Colombian Peso (COP)
  • Costa Rican Colón (CRC)
  • Cuban Peso (CUP)
  • Cape Verdean Escudo (CVE)
  • Czech Koruna (CZK)
  • Djiboutian Franc (DJF)
  • Danish Krone (DKK)
  • Dominican Peso (DOP)
  • Algerian Dinar (DZD)
  • Egyptian Pound (EGP)
  • Eritrean Nakfa (ERN)
  • Ethiopian Birr (ETB)
  • Euro (EUR)
  • Fijian Dollar (FJD)
  • Falkland Islands Pound (FKP)
  • British Pound (GBP)
  • Georgian Lari (GEL)
  • Ghanaian Cedi (GHS)
  • Gibraltar Pound (GIP)
  • Gambian Dalasi (GMD)
  • Guinean Franc (GNF)
  • Guatemalan Quetzal (GTQ)
  • Guyanese Dollar (GYD)
  • Hong Kong Dollar (HKD)
  • Honduran Lempira (HNL)
  • Croatian Kuna (HRK)
  • Haitian Gourde (HTG)
  • Hungarian Forint (HUF)
  • Indonesian Rupiah (IDR)
  • Israeli New Shekel (ILS)
  • Iraqi Dinar (IQD)
  • Iranian Rial (IRR)
  • Icelandic Króna (ISK)
  • Jamaican Dollar (JMD)
  • Jordanian Dinar (JOD)
  • Japanese Yen (JPY)
  • Kenyan Shilling (KES)
  • Kyrgyzstani Som (KGS)
  • Cambodian Riel (KHR)
  • Comorian Franc (KMF)
  • South Korean Won (KRW)
  • Kuwaiti Dinar (KWD)
  • Cayman Islands Dollar (KYD)
  • Kazakhstani Tenge (KZT)
  • Lao Kip (LAK)
  • Lebanese Pound (LBP)
  • Sri Lankan Rupee (LKR)
  • Liberian Dollar (LRD)
  • Lesotho Loti (LSL)
  • Libyan Dinar (LYD)
  • Moroccan Dirham (MAD)
  • Moldovan Leu (MDL)
  • Malagasy Ariary (MGA)
  • Macedonian Denar (MKD)
  • Burmese Kyat (MMK)
  • Mongolian Tögrög (MNT)
  • Macanese Pataca (MOP)
  • Mauritian Rupee (MUR)
  • Maldivian Rufiyaa (MVR)
  • Malawian Kwacha (MWK)
  • Mexican Peso (MXN)
  • Malaysian Ringgit (MYR)
  • Mozambican Metical (MZN)
  • Namibian Dollar (NAD)
  • Nigerian Naira (NGN)
  • Nicaraguan Córdoba (NIO)
  • Norwegian Krone (NOK)
  • Nepalese Rupee (NPR)
  • New Zealand Dollar (NZD)
  • Omani Rial (OMR)
  • Panamanian Balboa (PAB)
  • Peruvian Sol (PEN)
  • Papua New Guinean Kina (PGK)
  • Philippine Peso (PHP)
  • Pakistani Rupee (PKR)
  • Polish Złoty (PLN)
  • Paraguayan Guaraní (PYG)
  • Qatari Riyal (QAR)
  • Romanian Leu (RON)
  • Serbian Dinar (RSD)
  • Russian Ruble (RUB)
  • Rwandan Franc (RWF)
  • Saudi Riyal (SAR)
  • Solomon Islands Dollar (SBD)
  • Seychellois Rupee (SCR)
  • Sudanese Pound (SDG)
  • Swedish Krona (SEK)
  • Singapore Dollar (SGD)
  • Saint Helena Pound (SHP)
  • Sierra Leonean Leone (SLL)
  • Somali Shilling (SOS)
  • Surinamese Dollar (SRD)
  • São Tomé and Príncipe Dobra (STD)
  • Syrian Pound (SYP)
  • Swazi Lilangeni (SZL)
  • Thai Baht (THB)
  • Tajikistani Somoni (TJS)
  • Turkmenistani Manat (TMT)
  • Tunisian Dinar (TND)
  • Tongan Paʻanga (TOP)
  • Turkish Lira (TRY)
  • Trinidad and Tobago Dollar (TTD)
  • New Taiwan Dollar (TWD)
  • Tanzanian Shilling (TZS)
  • Ukrainian Hryvnia (UAH)
  • Ugandan Shilling (UGX)
  • United States Dollar (USD)
  • Uruguayan Peso (UYU)
  • Uzbekistani Som (UZS)
  • Vietnamese Đồng (VND)
  • Vanuatu Vatu (VUV)
  • Samoan Tālā (WST)
  • Central African CFA Franc (XAF)
  • East Caribbean Dollar (XCD)
  • West African CFA franc (XOF)
  • CFP Franc (XPF)
  • Yemeni Rial (YER)
  • South African Rand (ZAR)
  • Zambian Kwacha (ZMW)
  • Zimbabwean Dollar (ZWL)

$0.00

+ applicable taxes

Proposal turnaround typically 24–48 hours

Note: Estimate is indicative only. Final pricing is subject to scope finalization after discovery call.

REFERENCE CASELETS

Reference

Real-world examples of survey work in the pharma distribution and HCP engagement space.

CASELET 1

Medical rep detailing frequency & HCP prescription influence (India)

CASELET 2

Stockist advisory trust & channel conflict perception study (West India)

Medical rep detailing frequency & HCP prescription influence (India)

OBJECTIVE

A specialty pharma distributor needed to quantify how detailing visit frequency and sample drop volume shaped prescription preference among general practitioners and specialist physicians across Tier 1 and Tier 2 cities.

WHAT WE DID

Ran a structured quant survey across 320 HCPs in 8 cities, capturing rep visit cadence, sample acceptance rate, brand recall scores, and the gap between samples received and prescriptions subsequently written per therapeutic category.

DELIVERED

A detailing-to-prescription conversion map by HCP segment, a ranked sample-push effectiveness index by therapeutic category, and a visit frequency corridor that identified the threshold beyond which incremental rep visits produced no measurable prescription lift.
CASELET 1

Medical rep detailing frequency & HCP prescription influence (India)

CASELET 2

Stockist advisory trust & channel conflict perception study (West India)

Medical rep detailing frequency & HCP prescription influence (India)

OBJECTIVE

A specialty pharma distributor needed to quantify how detailing visit frequency and sample drop volume shaped prescription preference among general practitioners and specialist physicians across Tier 1 and Tier 2 cities.

WHAT WE DID

Ran a structured quant survey across 320 HCPs in 8 cities, capturing rep visit cadence, sample acceptance rate, brand recall scores, and the gap between samples received and prescriptions subsequently written per therapeutic category.

DELIVERED

A detailing-to-prescription conversion map by HCP segment, a ranked sample-push effectiveness index by therapeutic category, and a visit frequency corridor that identified the threshold beyond which incremental rep visits produced no measurable prescription lift.

FREQUENTLY ASKED QUESTIONS

Common Questions

Answers to frequently asked questions about this survey mandate.

What decisions will this survey enable?

Who is the buyer vs who are the respondents?

Can we see differences between primary care HCPs, specialist HCPs and hospital formulary decision-makers?

How will you measure HCP advisory influence on sample push behaviour beyond simple ratings?

Will the survey map the full sample distribution journey and drop-offs?

Can this survey inform product and pricing strategy?

How will findings improve our medical rep deployment and sample allocation planning?

Still have questions?

Schedule a discovery call to discuss your specific needs and get a custom quote.

Book a Discovery Call